This filing is a routine reaffirmation of existing guidance with no new information. Traders should monitor the next quarterly earnings report for any changes to the outlook or operational trends.
Price Chart
Executive Summary
Elevance Health filed an 8-K to reaffirm its full-year 2026 guidance during upcoming investor meetings. The company expects adjusted shareholders' earnings of at least $27.00 per diluted share and a benefit expense ratio of 90.2% ± 50 bps. This is a routine reaffirmation of existing guidance with no new financial data or changes to the outlook, making it a non-event for traders.
Key Facts
- Reaffirmed FY2026 adjusted shareholders' earnings guidance of at least $27.00 per diluted share.
- Reaffirmed FY2026 GAAP shareholders' earnings guidance of at least $20.10 per diluted share, including ~$6.90 of net unfavorable items.
- Reaffirmed FY2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.
- No new financial data or changes to prior guidance were provided.
Financial Impact
No new financial impact; existing guidance reaffirmed with no changes.
Risk Factors
- Healthcare cost and utilization trends could pressure the benefit expense ratio.
- Medicare and Medicaid regulatory changes could impact future earnings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001156039-26-000063 |
| Document: 0001156039-26-000063-index-headers.html | 0001156039-26-000063 |
| Document: 0001156039-26-000063-index.html | 0001156039-26-000063 |
| Document: 0001156039-26-000063.txt | 0001156039-26-000063 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | 8-K | $416.54 $414.26 | ▼ −0.55% | ▼ −0.05% | $381.34 (−8.45%) |
Aug 27, 2026 5w ago | Institutional Cluster | $399.11 $414.78 | ▲ +3.93% | ▲ +3.66% | $381.34 (−4.45%) |
Aug 20, 2026 6w ago | Court Ruling | $396.28 $399.11 | ▲ +0.71% | ▼ −0.40% | $381.34 (−3.77%) |
Aug 17, 2026 6w ago | Court Ruling | $390.24 $402.63 | ▲ +3.17% | ▲ +4.37% | $381.34 (−2.28%) |
Jul 17, 2026 10w ago | Insider Cluster | $373.11 $379.31 | ▲ +1.66% | ▲ +2.35% | $381.34 (+2.21%) |
Jul 15, 2026 11w ago | 8-K | $390.33 $389.09 | ▼ −0.32% | ▲ +0.66% | $381.34 (−2.30%) |
Jun 15, 2026 15w ago | Insider Cluster | $397.80 $395.10 | ▼ −0.68% | ▲ +1.55% | $381.34 (−4.14%) |
Jun 10, 2026 16w ago | 8-K | $404.56 $397.80 | ▼ −1.67% | ▼ −5.10% | $381.34 (−5.74%) |
Apr 22, 2026 23w ago | 8-K | $328.20 $368.75 | ▼ −12.36% | ▼ −12.30% | $381.34 (−16.19%) |
Mar 27, 2026 26w ago | DEFA14A | $284.79 $311.83 | ▲ +9.49% | ▲ +5.19% | $381.34 (+33.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access